Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages

  Wu, Zhi Min ^a   Ling, Li ^a   Zhou, Li Ying ^b   Guo, Xin Dong ^a   Jiang, Wei ^a   Qian, Yu ^a   Luo, Kathy Qian ^c   Zhang, Li Juan ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c Nanyang Technological University   (Singapore)

Author keywords

Diabetes; Multiple emulsions; Oral insulin; Ph sensitive nanoparticles

Indexed keywords

BIOCHEMISTRY; EMULSIFICATION; MEDICAL PROBLEMS; NANOPARTICLES; RATS;

ENCAPSULATION EFFICIENCY; HYPOGLYCEMIC EFFECT; MULTIPLE EMULSIONS; ORAL INSULIN DELIVERY; PH SENSITIVE; PHYSICOCHEMICAL CHARACTERISTICS; RELATIVE BIOAVAILABILITY; SIMULATED GASTROINTESTINAL CONDITIONS;

INSULIN;

RATTUS;

EID: 84864023319     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-299     Document Type: Article

References (42)

1. Daneman D: Type 1 diabetes. Lancet 2006, 367(9513):847-858.
2. Sabetsky V, Ekblom J: Insulin: a new era for an old hormone. Pharmacol Res 2010, 61(1):1-4.
3. Zambanini A, Newson RB, Maisey M, Feher MD: Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999, 46(3):239-246.
4. Gowthamarajan K, Kulkarni G: Oral insulin: fact or fiction? Resonance 2003, 8(5):38-46.
5. Owens DR, Zinman B, Bolli G: Alternative routes of insulin delivery. Diabet Med 2003, 20(11):886-898.
6. Khafagy ES, Morishita M, Onuki Y, Takayama K: Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 2007, 59(15):1521-1546.
7. Lowman AM, Morishita M, Kajita M, Nagai T, Peppas NA: Oral delivery of insulin using pH-responsive complexation gels. J Pharm Sci 1999, 88(9):933-937.
8. Nho YC, Park SE, Kim HI, Hwang TS: Oral delivery of insulin using pH-sensitive hydrogels based on polyvinyl alcohol grafted with acrylic acid/methacrylic acid by radiation. Nucl Instrum Meth B 2005, 236:283-288.
9. Makhlof A, Tozuka Y, Takeuchi H: Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2010, 42(5):445-451.
10. Woitiski CB, Carvalho RA, Ribeiro AJ, Neufeld RJ, Veiga F: Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation. BioDrugs 2008, 22(4):223-237.
11. Des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V: Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Controlled Release 2006, 116(1):1-27.
12. Damge C, Reis CP, Maincent P: Nanoparticle strategies for the oral delivery of insulin. Expert Opin Drug Deliv 2008, 5(1):45-68.
13. Sajeesh S, Sharma CP: Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm 2006, 325(1-2):147-154.
14. Sajeesh S, Sharma CP: Interpolymer complex microparticles based on polymethacrylic acid-chitosan for oral insulin delivery. J Appl Polym Sci 2006, 99(2):506-512.
15. Deutel B, Greindl M, Thaurer M, Bernkop-Schnuerch A: Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. Biomacromolecules 2008, 9(1):278-285.
16. Cui F, Qian F, Zhao Z, Yin L, Tang C, Yin C: Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules 2009, 10(5):1253-1258.
17. Sajeesh S, Vauthier C, Gueutin C, Ponchel G, Sharma CP: Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. Acta Biomater 2010, 6(8):3072-3080.
18. Jelvehgari M, Zakeri-Milani P, Siahi-Shadbad MR, Delf Loveymi B, Nokhodchi A, Azari Z, Valizadeh H: Development of pH-sensitive insulin nanoparticles using Eudragit L100- 55 and chitosan with different molecular weights. AAPS PharmSciTech 2010, 11(3):1237-1242.
19. Cui FD, Tao AJ, Cun DM, Zhang LQ, Shi K: Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci 2007, 96(2):421-427.
20. Martins S, Sarmento B, Souto EB, Ferreira DC: Insulin-loaded alginate microspheres for oral delivery - effect of polysaccharide reinforcement on physicochemical properties and release profile. Carbohydr Polym 2007, 69(4):725-731.
21. Reis C, Ribeiro A, Houng S, Veiga F, Neufeld R: Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity. Eur J Pharm Sci 2007, 30(5):392-397.
22. Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R: Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 2007, 8(10):3054-3060.
23. Woitiski C, Neufeld R, Veiga F, Carvalho R, Figueiredo I: Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci 2010, 41(3):556-563.
24. Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D: Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 2007, 24(12):2198-2206.
25. Lin YH, Chen CT, Liang HF, Kulkarni AR, Lee PW, Chen CH, Sung HW: Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology 2007, 18(10):1-11.
26. Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW: In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 2009, 30(12):2329-2339.
27. Sonaje K, Lin KJ, Wey SP, Lin CK, Yeh TH, Nguyen HN, Hsu CW, Yen TC, Juang JH, Sung HW: Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials 2010, 31(26):6849-6858.
28. Damge C, Socha M, Ubrich N, Maincent P: Poly(epsilon-caprolactone)/Eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes. J Pharm Sci 2010, 99(2):879-889.
29. Damge C, Maincent P, Ubrich N: Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Controlled Release 2007, 117(2):163-170.
30. Bendayan M, Ziv E, Ben-Sasson R, Bar-On H, Kidron M: Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium. Diabetologia 1990, 33(4):197-204.
31. Ma Z, Lim TM, Lim LY: Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm 2005, 293(1-2):271-280.
32. Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, Hao JS, Cui FD: Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002, 249(1-2):139-147.
33. Milstein SJ, Leipold H, Sarubbi D, Leone-Bay A, Mlynek GM, Robinson JR, Kasimova M, Freire E: Partially unfolded proteins efficiently penetrate cell membranes - implications for oral drug delivery. J Controlled Release 1998, 53(1-3):259-267.
34. Stoll BR, Batycky RP, Leipold HR, Milstein S, Edwards DA: A theory of molecular absorption from the small intestine. Chem Eng Sci 2000, 55(3):473-489.
35. Morishita M, Morishita I, Takayama K, Machida Y, Nagai T: Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin. Biol Pharm Bull 1993, 16(1):68-72.
36. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS: PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Controlled Release 1999, 57(2):171-185.
37. Xu XL, Fu Y, Hu HY, Duan YR, Zhang ZR: Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography. J Pharm Biomed Anal 2006, 41(1):266-273.
38. Vauthier C, Bouchemal K: Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009, 26(5):1025-1058.
39. Chen H, Zheng Y, Tian G, Tian Y, Zeng X, Liu G, Liu K, Li L, Li Z, Mei L, Huang L: Oral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy. Nanoscale Res Lett 2011, 6(1):1-10.
40. Bendayan M, Ziv E, Gingras D, Ben-Sasson R, Bar-On H, Kidron M: Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa. Diabetologia 1994, 37(2):119-126.
41. Ziv E, Bendayan M: Intestinal absorption of peptides through the enterocytes. Microsc Res Tech 2000, 49(4):346-352.
42. Fallingborg J: Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 1999, 46(3):183-196.